Gene: CTAG1A ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 246100
Gene Symbol: CTAG1A
CTAG1A 		0.050 Biomarker disease BEFREE With lead times ≤6 months, ovarian cancer detection sensitivity at 0.98 specificity (SE98) varied from 0.19 [95% CI 0.08-0.40] for CTAG1A, CTAG2 and NUDT1 to 0.23 [0.10-0.44] for P53 (0.33 [0.11-0.68] for high-grade serous tumors). 29473162 2018
Entrez Id: 246100
Gene Symbol: CTAG1A
CTAG1A 		0.050 Biomarker disease BEFREE The purpose of this study was to determine the expression frequency, immunogenicity, and clinical impact of NY-ESO-1 in ovarian cancer. 28392127 2017
Entrez Id: 246100
Gene Symbol: CTAG1A
CTAG1A 		0.050 Biomarker disease BEFREE Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer. 24535937 2014
Entrez Id: 246100
Gene Symbol: CTAG1A
CTAG1A 		0.050 AlteredExpression disease BEFREE Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients. 22454499 2012
Entrez Id: 246100
Gene Symbol: CTAG1A
CTAG1A 		0.050 PosttranslationalModification disease BEFREE Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer. 18519754 2008